ストックスクリーナーアプリを入手
36.90
0.39%
0.1448
前日終値:
$36.76
開ける：
$36.75
24時間の取引高:
146.51K
Relative Volume:
0.19
時価総額：
$2.13B
収益：
$772.53M
当期純損益:
$180.90M
株価収益率:
11.90
EPS:
3.1024
ネットキャッシュフロー:
$258.73M
1週間 パフォーマンス:
+1.89%
1か月 パフォーマンス:
-3.99%
6か月 パフォーマンス:
-0.85%
1年 パフォーマンス:
-2.91%
1日の値動き範囲:
$36.42
$37.41
1週間の範囲:
$35.16
$37.41
52週間の値動き範囲:
$25.52
$40.87
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
36.91 | 2.12B | 772.53M | 180.90M | 258.73M | 3.1024 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.42 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.75 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
815.50 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.88 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.98 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Harmony’s WAKIX Surges Toward Blockbuster Status as Revenue Nears $1 Billion - mychesco.com
Discipline and Rules-Based Execution in HRMY Response - Stock Traders Daily
Stock Recap: Can Harmony Biosciences Holdings Inc reach all time highs this yearMarket Sentiment Report & Short-Term Trading Alerts - baoquankhu1.vn
Harmony Biosciences (NASDAQ:HRMY) CFO Sells $752,919.12 in Stock - MarketBeat
Harmony Biosciences CFO Kapadia sells $752k in stock By Investing.com - Investing.com Nigeria
Harmony Biosciences CFO Kapadia sells $752k in stock - Investing.com
Earnings Beat: Is Harmony Biosciences Holdings Inc part of any ETF2025 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn
Harmony Biosciences Projects WAKIX Revenue to Surpass $1 Billion in 2026 - Sleep Review
Harmony Biosciences stock drops after ZYN002 exit as 2026 Wakix sales outlook tops $1 billion - TechStock²
HRMY: WAKIX nears blockbuster status as pipeline and commercial expansion drive growth into 2026 - TradingView — Track All Markets
Harmony Biosciences (NASDAQ:HRMY) Stock Price Down 7.4%Here's Why - MarketBeat
Harmony Biosciences (HRMY) is an Incredible Growth Stock: 3 Reasons Why - sharewise.com
Buy Signal: Is Harmony Biosciences Holdings Inc. stock a buy before product launchesEarnings Miss & Precise Entry and Exit Recommendations - Bộ Nội Vụ
Harmony Biosciences projects 2026 WAKIX revenue to exceed $1 billion By Investing.com - Investing.com Nigeria
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation - BioSpace
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $37 at Goldman Sachs - StreetInsider
Harmony Biosciences forecasts WAKIX revenue to exceed $1 billion in 2026 - StreetInsider
Harmony Biosciences projects 2026 WAKIX revenue to exceed $1 billion - Investing.com
J.P. Morgan Healthcare Conference - MarketScreener
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q4 Earnings and Revenue Estimates - MSN
Harmony Biosciences' chief commercial officer sells $551,575 in stock - MSN
Is Harmony Biosciences Holdings Inc. stock positioned well for digital economy2025 AllTime Highs & Verified Stock Trade Ideas - Улправда
Is Harmony Biosciences (HRMY) Pricing Reflect Future Growth After Recent Mixed Share Performance - Yahoo Finance
How to contact the Daily Bulletin - FinancialContent
Assessing Harmony Biosciences (HRMY) Valuation After Fresh Clinical Trial Progress In Rare Neurological Disorders - Sahm
Will Harmony Biosciences Holdings Inc. stock outperform growth indexesNew Guidance & Weekly High Conviction Ideas - ulpravda.ru
Why Harmony Biosciences Holdings Inc. stock attracts high net worth investorsWeekly Trend Recap & Short-Term Trading Alerts - Улправда
Bank Watch: Is Harmony Biosciences Holdings Inc. stock positioned well for digital economyEarnings Performance Report & Fast Exit Strategy with Risk Control - Улправда
Market Wrap: Why Harmony Biosciences Holdings Inc. stock attracts high net worth investorsTrade Ideas & Reliable Price Breakout Signals - Улправда
6 Analysts Have This To Say About Harmony Biosciences Hldgs - Benzinga
Are Strong Financial Prospects The Force That Is Driving The Momentum In Harmony Biosciences Holdings, Inc.'s NASDAQ:HRMY) Stock? - 富途牛牛
Truist Securities Lowers Price Target for HRMY Amidst Current Buy Rating | HRMY Stock News - GuruFocus
HRMY vs. LQDA: Which Stock Is the Better Value Option? - Yahoo Finance
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? - Yahoo Finance
Harmony Biosciences Holdings, Inc.Common Stock (NQ: HRMY - FinancialContent
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Investing News Network
Oklahoma City NewsThe Oklahoman - FinancialContent
Harmony Biosciences Holdings (HRMY) Stock Analysis: A Revenue Growth Powerhouse with 25.66% Upside Potential - DirectorsTalk Interviews
Harmony Biosciences Launches Early Trial of Promising Orexin Agonist - MSN
Market Might Still Lack Some Conviction On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Even After 26% Share Price Boost - 富途牛牛
Top 5 US Stocks To Buy In January 2026 - Investing.com
(HRMY) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
26,279 Shares in Harmony Biosciences Holdings, Inc. $HRMY Acquired by Paradiem LLC - MarketBeat
Exchange Traded Concepts LLC Buys 32,923 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings Inc Stock Analysis and ForecastContrarian Investment Ideas & Big Gains Small Trading - earlytimes.in
Quarterly Trades: What is the fair value of Harmony Biosciences Holdings Inc stock nowTrade Risk Summary & Daily Oversold Stock Bounce Ideas - Bộ Nội Vụ
Why Harmony Biosciences Holdings Inc. stock is popular among millennials2025 Growth vs Value & Daily Market Momentum Tracking - Улправда
Price-Driven Insight from (HRMY) for Rule-Based Strategy - Stock Traders Daily
Can Harmony Biosciences Holdings Inc. stock maintain operating marginsJuly 2025 Gainers & Reliable Volume Spike Alerts - Улправда
Harmony’s Epilepsy Drug Cuts Seizures in Half in Key Late-Stage Study - MyChesCo
Why Harmony Biosciences Holdings Inc. stock appeals to dividend seekersJuly 2025 Outlook & Verified Chart Pattern Trade Signals - DonanımHaber
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
3.31%
2.06%
大文字化:
|
ボリューム (24 時間):